Product
AI AGENTS
INTELLIGENCE SUITE
API, MCP & INTEGRATION
Solutions
INDUSTRIES
USE CASES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
Patsnap Eureka Platform
IP Search Agents
IP Drafting Agents
Engineering Agents
Find Solutions with TRIZ
Life Sciences Agents
Materials Agents
SEP Agents
Patsnap Eureka Desktop
BetaAnalytics
IP IntelligenceSynapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisProfessional Services
Open Platform
Developer Center
Customer Stories
Newsroom
Blog
Global Innovation Report
Glossary
Webinars & Training
User Community
R&D Benchmark Calculator
Trust and Security
PatentBench
NEWLLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
Unlock professional features and history
Already have an account? Log In
To start using Patsnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report How Micron's 621 HBM patents and SK Hynix's 50% market share define the HBM2E-to-HBM4 race. Deep-dive patent strategy, DRAM architecture, and 2026 outlook.
Article | Report Deep analysis of WO2019044947A1: T-DXd GGFG linker chemistry, DXd payload conjugation, DAR 7-8 optimization, and how these structural innovations widen the therapeutic index vs. T-DM1.
Article | Report How CNS-penetrant BTK inhibitors tolebrutinib and fenebrutinib target smoldering neuroinflammation differently from anti-CD20 therapies in MS.
Article | Report 124,263 active patents, two divergent markets: how wearable health sensors and industrial robotics tactile sensors are reshaping the $2.21B stretchable electronics landscape.
Article | Report Analyse BeiGene's BTK degrader BGB-16673 (Catadegbrutinib): PROTAC linker architecture, E3 ligase recruitment, DC50 values, and key patent family findings.
Article | Report How does TL1A inhibition differ from anti-TNF and anti-integrin therapies in IBD? Explore tulisokibart and RVT-3101 clinical data, mechanisms, and non-responder potential.
Article | Report ASML's lithography roadmap from DUV to High-NA EUV: 4,995 patents, 220 WPH throughput, and 0.55 NA systems enabling 8nm single-exposure resolution for sub-2nm nodes.
Article | Report How bispecific ADCs mechanistically overcome tumor heterogeneity and antigen escape in solid tumors—with 40–60% greater coverage than monospecific ADCs.
Article | Report Compare pan-RAS molecular glue inhibitors (daraxonrasib, BI-2865) vs. covalent KRAS G12C inhibitors (sotorasib, adagrasib): mechanisms, resistance, and clinical scope.
Article | Report FeCrAl cladding reaches TRL 7, SiC/SiC stays at TRL 4-5, and molten salt corrosion data gaps persist. The definitive 2026 SMR materials qualification guide.
Article | Report Pneumatic, SMA, and DEA actuators compared: force output, energy efficiency, patent trends, and application readiness across medical, industrial, and wearable robotics.
Article | Report How Pfizer/BioNTech and Moderna are racing from COVID-19 to oncology and influenza with diverging mRNA patent strategies and 73 combined pipeline candidates.
Article | Report Five proven technical pathways to improve harmonic drive flexspline wear resistance in humanoid robots — zero mass penalty, no lubrication maintenance required.
Article | Report Toyota's fuel cell, solid-state battery, and hybrid patent roadmap 2010–2026: 6,311 patents, three strategic pillars, and a 2027 solid-state launch target analysed.
Article | Report Pneumatic, shape memory alloy, and dielectric elastomer actuators compared: patent trends, performance trade-offs, and R&D opportunities in soft robotics 2026.